MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells

Cell Death and Disease

Volumn 4, Issue 11, 2013, Pages

  Liu, X ^a   Chen, Q ^a   Yan, J ^a   Wang, Y ^a   Zhu, C ^a   Chen, C ^a   Zhao, X ^a   Xu, M ^a   Sun, Q ^a   Deng, R ^a   Zhang, H ^a   Qu, Y ^a   Huang, J ^a   Jiang, B ^b   Yu, J ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b School of Medicine   (China)

Author keywords

ICAM 1; Metastasis; miR 296 3p; NK cells; Prostate cancer

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MICRORNA; MICRORNA 296 3P; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CIRCULATING TUMOR CELL; CONTROLLED STUDY; CYTOLYSIS; EX VIVO STUDY; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS; METASTASIS POTENTIAL; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TISSUE MICROARRAY; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOBLOTTING; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, NATURAL; MALE; MICRORNAS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84889594198     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.458     Document Type: Article

References (45)

1. Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012; 61: 1079-1092
2. Gupta GP, Massague J. Cancer metastasis: Building a framework. Cell 2006; 127: 679-695
3. Valastyan S, Weinberg RA. Tumor metastasis: Molecular insights and evolving paradigms. Cell 2011; 147: 275-292
4. Schilling D, Todenhofer T, Hennenlotter J, Schwentner C, Fehm T, Stenzl A. Isolated, disseminated and circulating tumour cells in prostate cancer. Nat Rev Urol 2012; 9: 448-463
5. Fidler IJ. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-458
6. Jacob K, Sollier C, Jabado N. Circulating tumor cells: Detection, molecular profiling and future prospects. Expert Rev Proteomics 2007; 4: 741-756
7. Hanna N. Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev 1982; 1: 45-64
8. Barber DF, Faure M, Long EO. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol 2004; 173: 3653-3659
9. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. Shedding of ICAM-1 from human melanoma cell lines induced by ifn-gamma and tumor necrosis factor-Alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 1991; 147: 4398-4401
10. Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, et al. Human microRNAs regulate stress-induced immune responses mediated by the receptor nkg2d. Nat Immunol 2008; 9: 1065-1073
11. Himmelreich H, Mathys A, Wodnar-Filipowicz A, Kalberer CP. Post-Transcriptional regulation of ULBP1 ligand for the activating immunoreceptor NKG2D involves 3' untranslated region. Hum Immunol 2011; 72: 470-478
12. Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber ER, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic t-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci USA 2009; 106: 10746-10751
13. Hu G, Gong AY, Liu J, Zhou R, Deng C, Chen XM. Mir-221 suppresses ICAM-1 translation and regulates interferon-gamma-induced ICAM-1 expression in human cholangiocytes. Am J Physiol Gastrointestinal Liver Physiol 2010; 298: G542-G550
14. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 1994; 58: 721-729
15. Bae VL, Jackson-Cook CK, Maygarden SJ, Plymate SR, Chen J, Ware JL. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate 1998; 34: 275-282
16. Ke N, Wang X, Xu X, Abassi YA. The xcelligence system for real-Time and label-free monitoring of cell viability. Methods Mol Biol 2011; 740: 33-43
17. Golke A, Cymerys J, Slonska A, Dzieciatkowski T, Chmielewska A, Tucholska A, et al. The xcelligence system for real-Time and label-free analysis of neuronal and dermal cell response to equine herpesvirus type 1 infection. Pol J Vet Sci 2012; 15: 151-153
18. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-193
19. Liu X, Wang Y, Sun Q, Yan J, Huang J, Zhu S, et al. Identification of microRNA transcriptome involved in human natural killer cell activation. Immunol Lett 2012; 143: 208-217
20. Denman CJ, Senyukov VV, Somanchi SS, Phatarpekar PV, Kopp LM, Johnson JL, et al. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One 2012; 7: E30264
21. Waldhauer I, Steinle A. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res 2006; 66: 2520-2526
22. Gross CC, Brzostowski JA, Liu D, Long EO. Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization. J Immunol 2010; 185: 2918-2926
23. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling ofmicroRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 2010; 11: R90
24. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007; 446: 765-770
25. Kasai M, Yoneda T, Habu S, Maruyama Y, Okumura K, Tokunaga T. In vivo effect of antiasialo gm1 antibody on natural killer activity. Nature 1981; 291: 334-335
26. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for t(h)1 priming. Nat Immunol 2004; 5: 1260-1265
27. Kim S, Iizuka K, Aguila HL, Weissman IL, Yokoyama WM. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci USA 2000; 97: 2731-2736
28. Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193: 661-670
29. Hanna N, Burton RC. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. J Immunol 1981; 127: 1754-1758
30. Barlozzari T, Reynolds CW, Herberman RB. In vivo role of natural killer cells: Involvement of large granular lymphocytes in the clearance of tumor cells in anti-Asialo gm1-Treated rats. J Immunol 1983; 131: 1024-1027
31. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011; 11: 123-134
32. Ksienzyk A, Neumann B, Nandakumar R, Finsterbusch K, Grashoff M, Zawatzky R, et al. IRF-1 expression is essential for natural killer cells to suppress metastasis. Cancer Res 2011; 71: 6410-6418
33. Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, et al. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med 2004; 200: 1325-1335
34. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 2005; 202: 1001-1012
35. Perez OD, Mitchell D, Jager GC, Nolan GP. LFA-1 signaling through p44/42 is coupled to perforin degranulation in CD56CD8 natural killer cells. Blood 2004; 104: 1083-1093
36. Luhm J, Brand JM, Koritke P, Hoppner M, Kirchner H, Frohn C. Large-scale generation of natural killer lymphocytes for clinical application. J Hematotherapy Stem Cell Res 2002; 11: 651-657
37. Klingemann HG, Martinson J. Ex vivo expansion of natural killer cells for clinical applications. Cytotherapy 2004; 6: 15-22
38. Ren H, Shen J, Tomiyama-Miyaji C, Watanabe M, Kainuma E, Inoue M, et al. Augmentation of innate immunity by low-dose irradiation. Cell Immunol 2006; 244: 50-56
39. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, et al. Host immune system gene targeting by a viral mirna. Science 2007; 317: 376-381
40. Yadav D, Ngolab J, Lim RS, Krishnamurthy S, Bui JD. Cutting edge: Down-regulation of MHC class I-related chain a on tumor cells by IFN-gamma-induced microRNA. J Immunol 2009; 182: 39-43
41. Plymate SR, Tennant M, Birnbaum RS, Thrasher JB, Chatta G, Ware JL. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J Clin Endocrinol Metab 1996; 81: 3709-3716
42. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-Time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: E179
43. Neri S, Mariani E, Meneghetti A, Cattini L, Facchini A. Calcein-Acetyoxymethyl cytotoxicity assay: Standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagnostic Lab Immunol 2001; 8: 1131-1135
44. Alter G, Malenfant JM, Altfeld M. CD107A as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15-22
45. Huang J, Yan J, Zhang J, Zhu S, Wang Y, Shi T, et al. Sumo1 modification of pten regulates tumorigenesis by controlling its association with the plasma membrane. Nat Commun 2012; 3: 911